The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Johnpwh, maybe you are right but the experts don't agree with you. A vast array of publications and research papers state that Brands survive best in recessions. In fact the brands that Haleon own are in the best sector for survival. See
https://brandfinance.com/insights/how-brands-can-overcome-crises
I draw everyone's attention to the table "Anticipated Loss in Brand Value by Sector in Response to Related Covid-19 Crises". This is no longer a Covid crisis but evidence is in plenty of sources. Here is a £2.69 book that can educate us all:
https://www.amazon.co.uk/Brand-Success-Worlds-Brands-Survive/dp/0749462876
If you are cheapskate you can always read the summary provided by Amazon.
Boxthefox, I thought GSK were transparent in the prospectus, on the debt and dividends. Please read page 12 for the debt provision and dividend payments to GSK as Balancing Dividend, Pre-Demerger Dividend and Sweep-up Dividend.
As for future dividends they spell this out on page 15.
Certainly on the debt there has been plenty of material published on the internet, that GSK was to load Haleon with a certain debt and they flagged this as a concern.
I don't believe so. The profit and dividend was accumulated under the GSK ownership. The trading statement indicates that both GSK and Pfizer were paid a dividend by Haleon. I would be surprised to see a dividend after less than a month of trading.
To keep you all in the loop and to save Abcam the hassle of responding to everyone here is my response from them:
"...the Board of Directors have decided to pursue a sole listing on NASDAQ and will continue consulting with shareholders for approval to delist from AIM at a General Meeting later this year. Today, our shares are convertible on a 1:1 basis from AIM to American Depository Shares (ADSs) listed on NASDAQ. If we were to go through the process of delisting, in line with precedent, we anticipate there to be mechanisms in place to facilitate this conversion and support existing AIM ordinary shareholders.
We will continue to communicate with all shareholders in the coming months and will provide further details of the impact and the options available to all shareholders, including the publication of a circular which will cover all material information on the specifics on the matter, ahead of an expected shareholder vote later in the year."
Trouts, I contacted my provider and they said they are waiting on further information from Abcam before offering advice and actions.
Alas_Smith, yes it does. Thank you.
Transactional costs (broking and currency) I guess will increase whether it is in an ISA or not as it does for my company SAYE scheme, where they are on the NYSE.
We know that they still need shareholders approval to pass this but it is likely that management will not have gone out on a limb without having the buy in of major shareholders. Though I know that a similar venture by Unilever ended up as a fiasco where the UK delisted eventually ended up as a Dutch delisting, when there was a major shareholder revolt.
Have to be honest I don't want an argument, all I want is a fair deal and I have large concerns this might not happen. It might be a case of watching this space and see how the press and major investors react to the proposal. Have gone to Abcam Investor relations website to ask questions, as I am so shocked. With the Nasdaq element it is almost as though the tail is wagging the dog.
I have seen that Abcam are to go sole listing on Nasdaq and therefore to cancel the Company's shares on AIM. I have not been in this position before and I am not on face value too happy about this. I am a LTSH of this stock and have been happy with the history and overall performance. This though is a kick in the teeth. The statement does not say what is happening to existing shareholders on the UK stock market.
Clearly this is a voluntary delisting, as they are still to trade on the Nasdaq and the question comes what happens to us. Will they offer to buy the shares off us at what could be a derogatory price? Paid a market price from the listing on the Nasdaq for the extra shares they sell to compensate? Offer us a deal that we can't refuse? Perhaps transfer our stock holding to the US, though I don't know how this affects an ISA? Leave us to trade over the counter?
If any of you have been through this on another company please let me know and let me know what happened? Were you better off, worse off or it balanced out?
I was most impressed with the webinar. All shareholders should listen to the 50+ minutes. Brian came across professional, personal and detailed, where he could be.
I took Q1 sales as an outlier and Q2 fell in line with sales expectations based on the Ukrainian conflict.
Expansion of Arupua is not planned nor easy to achieve. The absolute max output will be 320kt, unless a significant duplication of infrastructure takes place.
They will use Arupua to grow synergized products, initially limestone then phosphates, without having to dilute share holder value.
The lead time between a sale contract and ultimate payment can be a seasons growing cycle.
Different buyers have different purchasing/borrowing and price needs.
Both Volume and sales pricing is rising.
Profit margin is about 75%.
Q3 is anticipated to continue to be the largest sales/production period.
I congratulate all those who bought in at the 9p level, unfortunately I failed to act but my portfolio is already heavily weighted on HMI.
Chique, Q1 sales were a 689% increase compared to the same period last year and Q2 was a 165% increase . Hence my comment. As the Russian invasion of Ukraine largely impacted Q2 I was at least hoping for a similar robust sales performance to continue.
trading4good, who are you calling the trolls? We all know about smalleyus, so the plural concerns me.
I am hoping it is not me, if it is please read my past posts on HMI. Even here I tried to provide a balanced statement. I saw both the financial report for 2021 and the H1 2022 sales. Was not overly happy with both. I was waiting on the results to make a decision to increase my participation. Part of me was hoping that the Q1 sales growth would on a par with those of Q2 and it wasn't. I was hoping that the lack of potash delivery from Belarus through Lithuania would have caused the Brazilian farmers to rush to HMI, as an alternative. In fact the supply chain problems should have been been more beneficial for HMI in Q2 than Q1.
I am a LTH and work on macro economic issues. I am not close enough to the company to use it as a play.
Everything has a price level. The upset appears to be the constant draining of money by senior management and the lack of continued sales in Q2, compared to the great performance in Q1. The hidden good news is that the company has written off the legal case, at the request of the auditors, that could come back in and boost income at a later date.
Does anyone have a serious idea when the PEA will be published? Have been waiting patiently but apart from some peripheral data have not seen anything substantial.
Always good to see a company exceed market expectations and that is despite having debt provisions for Sri Lanka and the Chinese Real Estate problems which I thought might have had a bigger impact on the results. Overall pleased.
What is there not to like. I was expecting an improvement but not to the extent provided and over both to be separated businesses. All sectors up which bodes well. From the press agencies "Revenue in the first quarter of 2022 was GBP9.78 billion, up 32% from a year ago. Pretax profit jumped 71% to GBP2.60 billion from GBP1.52 billion year-on-year."
Do you believe that money will be coming our way, or will the money be reinvested to build up the business, such as the phosphate and limestone operations, where most of the money will required in Reals? It would be strange to pay dividends and then go cap in hand to the banks and borrow money at a higher rate. The exchange rate should increase or market capitalisation and therefore share price.
My opinion is this is the start of the long journey to establish a wider portfolio of fertilisers and remineralisers. Time will tell.
This news is 6 months old and was in the press back in November 2021:
https://www.morningstar.co.uk/uk/news/AN_1637931715575942300/in-brief-harvest-minerals-gets-nod-to-sell-fertiliser-in-paraguay.aspx
Swingy, I understand where you are coming from. This share is now 17.5% of my portfolio which in itself is not an issue but when I add up my other AIM stocks it accounts for over 50%. The dilemma for all the risk averse investors is where do I put the money to earn a better return, with less risk. At the moment I cannot see a better investment opportunity and can see me potentially increasing my participation.
Chique, where else can you make a relatively small investment and immediately own another 1/2000th of a company, that is largely derisked?
The PEA for the feasibility is to be completed in the 2nd half of this year. Based on a successful preliminary economic assessment, will significantly extend the life of the operation, should provide greater shareholder value and give the banks greater assurances for loaning money. The PEA will focus on trucking the ore from the mine head to the 15Mtpa Proyecto Riotinto production plant. Surprised that they plan to truck it the 28km and not conveyor it but I guess the team know that planning consents may be difficult. From an efficiency, environmental and cost standpoint a conveyor would be the best option.
Slicing is good if there is somewhere better to put your money. Struggling to think of a better sector. This is now worth almost 20% of my portfolio and I vowed I would only have 25% of it in the AIM. It has burst through 50%!!! "Sensible" has haemorrhaged money since Ukraine.